Antinutrient reduction enzymes sales will expand through 2036, with dry at 40.5% of form sales, poultry at 36.0% within the livestock segment and microbial at 33.5% of the source category in 2026. The market was valued at USD 496.8 million in 2025 and is forecast to record an 8.7% CAGR between 2026 and 2036.